Tuesday, August 29, 2006

Memantine

A letter in the CMAJ from Drs Gauthier and Herrman describing their current Lundbeck sponsored study on the possible anti-psychotic sparing properties of this NMDA receptor antagonist. The only province convinced of the benefit of this drug to date has been Quebec.

Use of memantine to treat Alzheimer's disease

No comments: